Natural Healing for Chronic Bronchitis

Dealing With Bronchitis

Dealing With Bronchitis

If you're wanting to know more about dealing with bronchitis... Then this may be the most important letter you'll ever read! You are About To Read The Most Important Information That Is Available To You Today, You Will Achieve A Better Understanding About Bronchitis! It doesn't matter if you've never had bronchitis before or never known anyone who has, This guide will tell you everything you need to know, without spending too much brainpower!

Get My Free Ebook

Relieve Your Bronchitis Cure

When you begin to take the specific natural ingredients outlined in the program you will be amazed at how you will really begin to feel the Phlegm and Mucus clear up nearly immediately! Within minutes of the first step you will feel the natural ingredients in action, targeting the specific root cause of the bronchitis. These ingredients will come in direct contact with the bacteria causing your infection, and get rid of them quickly. You will discover all the secrets I have come across while I was researching how to get rid of my own Bronchitis, and how you will not only get rid of your bronchitis, but actually prevent it from ever coming back again!

Relieve Your Bronchitis Cure Summary


4.6 stars out of 11 votes

Contents: EBook
Author: Richard Jones
Price: $24.97

My Relieve Your Bronchitis Cure Review

Highly Recommended

I usually find books written on this category hard to understand and full of jargon. But the writer was capable of presenting advanced techniques in an extremely easy to understand language.

In addition to being effective and its great ease of use, this eBook makes worth every penny of its price.

Download Now

Clinical Features and Diagnosis

A CD4 + T cell number of 200 mm or over and any of the following conditions fungal diseases, including candidiasis, coccidioidomycosis, cryptococcosis, histop-lasmosis, isosporiasis Pneumocystis carinii pneumonia cryptosporidosis, or toxoplasmosis of the brain, bacterial diseases including pulmonary tuberculosis and other Mycobacterium species, recurrent Salmonella septicaemia viral diseases, including cytomegalovirus infection, HIV-related encephalopathy, HIV wasting syndrome, chronic ulcer or bronchitis due to herpes simplex, or progressive multifocal leucoencephalopathy malignant diseases such as invasive cervical carcinoma, Kaposi sarcoma, Burkitt lymphoma, primary lymphoma of the brain, or im-munoblastic lymphoma recurrent pneumonia due to any age.

Prevention And Control

The most frequent reports of this type are trichomonads, normally assumed to be T. tenax, causing respiratory tract pathology (reviewed by Hersh, 1985) the same organism has been apparently found in the submaxillary gland and in children with chronic tonsillitis. Hiemstra et al. (1984) wondered whether T. vaginalis might cause pneumonia in newborn babies and unidentified species of trichomonad have been implicated in bronchitis and found in pleural fluid. In an interesting case of oesophageal

Beta receptor agonists

Various pharmacological agents alter the rheological function of mucus, which has been exploited particularly to thin mucus to aid in its clearance from the bronchi. Water, saline and mucolytic aerosols are important as aids in the removal of the bronchial secretions which accumulate in chronic bronchitis, bronchiectasis, cystic fibrosis and asthma. Inorganic and organic iodides act directly on mucus and are used therapeutically. Addition of potassium iodide reduces the apparent viscosity, presumably due to an effect of the halide on the configuration of the glycoprotein42. clearance, particularly in a hypertonic concentration where it facilitates expectoration41. It may liquefy sputum by enhancing chloride (and water) flux across the bronchial mucosa45. Mucolytic aerosols are also widely used N-acetyl-cysteine (Airbron) being best known in Britain, and 2 mercapto-ethane ethane sulphonate (Mistabron) in Europe. Mistabron appears to enhance mucociliary clearance in patients with...

Prevention And Control Pneumococcal Vaccines

Studies on the polysaccharide vaccine have produced variable results, but overall protective efficacy in preventing bacteraemic infection ranges from 50 to 70 (Mangtani, Cutts and Hall, 2003). The main drawbacks of this vaccine are its ineffectiveness at preventing nonbacteraemic pneumococcal pneumonia, otitis media and exacerbations of chronic bronchitis and inability to protect children below the age of 2 years and the immunocompromised. In addition, data from several Asian countries suggest that the 23 vaccine serotypes account for only 63 of infections, and serotype data from many parts of the world are scarce (Lee, Banks and Li, 1991).

Pathogenesis And Clinical Significance

Almost all of the organs of the human body can be infected by one or more of the spectrum of 14 microsporidian species described in the previous section. Many tissues and cell types are involved (Table 8.1). According to site of infection, clinical manifestations may be diarrhoea, weight loss, cholecystitis, cholangitis, bronchitis, bronchiolitis, pneumonitis, sinusitis, rhinitis, hepatitis, peritonitis, nephritis, ureteritis, cystitis, urethritis, prostatitis, keratoconjunctivitis, corneal ulcer, myositis or encephalitis. The pathology has been reviewed by Weber et al. (1994) and Schwartz et al. (1996). Cardiac disease and probable pancreatic, parathyroid and thyroid dysfunction have been reported for T. anthropophthera (Yachnis et al., 1996). Without treatment, the outcome is likely to be fatal for severely immunocompromised hosts infected with the disseminating species.

Antimicrobial Resistance

The genes encoding the methylases have been designated erm (erythromycin ribosome methylation). The methylases of the various species have been characterised at the molecular level and are subdivided into several classes, named by letters (Levy etal. 1999). In GAS the so-called ermB (ermAM) gene is among the most common, found to be present in 31 of 143 macrolide-resistant GAS lower respiratory tract infection strains obtained from 25 countries participating in the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin (PROTEKT) study during 1999-2000 (Farrell et al. 2002). A closely related gene, ermTR (ermA) (Seppala etal. 1998), was found in 23 of these isolates, whilst mefA, the resistance gene due to macrolide efflux (Levy et al. 1999), was detected in 46 of these strains.


Influenza is a highly infectious acute respiratory disease causing epidemics and pandemics throughout the world. While it is usually a self-limiting disease, it can be complicated by bronchitis and secondary bacterial pnuemonia, and in children by otitis media. Primary influenza virus pneumonia is rare but carries a high case fatality rate. Epidemics are generally associated with a large number of excess deaths among the elderly and among those with underlying chronic respiratory and cardiac diseases, renal or metabolic diseases and immunosuppression. Epidemics and pandemics occur at unpredictable intervals. The clinical picture is of abrupt onset of fever, malaise, headache, sore throat, myalgia, coryza and a dry cough lasting 2-5 days. The clinical features in children and in the elderly may differ in some respects and children may present with febrile convulsions, conjunctivitis, croup, otitis media, bronchitis and gastrointestinal symptoms. Diagnosis based on clinical presentation...


With increased elastic resistance, the work of breathing increases. The patient can try to compensate either by increasing the tidal volume or by breathing faster. When breathing difficulty is due to increased elasticity of the lungs or chest wall, the patient tends to compensate mainly by breathing faster, as it is too much work to deeply inspire. When it is resistance to flow that is increased, as occurs in the narrowing of the respiratory passages in asthma and chronic bronchitis, the patient often finds it less work to compensate by increasing the tidal volume rather than the rate. In fact, the rate of breathing may decrease. One of the simplest ways to assess respiratory function is to have the patient inspire maximally to total lung capacity and then to expire fully as rapidly as possible. The total volume of the expired air (the vital capacity) is low in restrictive lung disease, where expansion of the lung is restricted (respiratory compliance is low elastic rebound is high),...


Increased mucus secretion is brought about by cholinergic and a-adrenergic agonists which act directly on the mucus secreting cells of the submucosal gland. Serous secretions are stimulated by b-agonists or cholinergic stimulation, whereas the goblet cells do not appear to be innervated. The peripheral granules, in which the mucus is stored, are discharged continuously and form a reservoir which is secreted after exposure to an irritant stimulus. Disease states can drastically change the distribution of goblet cells and composition of respiratory tract fluids. Conditions such as chronic bronchitis are characterized by increased sputum and chronic irritation, leading to an increased number of glandular and goblet cells which result in a crowding of ciliated cells. Mucus transport is thus slowed and the increased viscosity of the mucus exacerbates the problem. Acute bronchitis Acute bronchitis most commonly occurs as a consequence of viral infection. It may also be precipitated by acute...

Urinary Tract Issues

Traveling tends to promote a change in a woman's vaginal ecosystem that may result in increased vaginal discharge and or itching. One of the most common causes of vaginitis is Candida albicans. This organism usually causes a thick cottage cheese discharge with vulvar and vaginal itching. The risk of yeast vaginitis is greater when doxycycline is used for malarial prophylaxis or other antibiotics are used for the treatment of travelers' diarrhea, bronchitis or urinary tract infections. Several intravaginal creams and suppositories are available over the counter (see Table 24.16). Due to the messiness of vaginal creams, some women prefer to use an oral treatment such as fluconazole (Diflucan). Other women prefer the creams, as they help with local itching. Both should be included in the travel medicine kit. A mild hydrocortisone cream may also be included for vaginal itching.